Great article. She probably should have come out a lot earlier but better late then never. Going to be some very interesting announcemts after her trip! Good to see companies changing to 'buy'! Good luck holders!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
